Teladoc Health (NYSE:TDOC) Price Target Raised to $118.00
Teladoc Health (NYSE:TDOC) had its price objective upped by equities research analysts at SunTrust Banks from $110.00 to $118.00 in a report released on Thursday, BenzingaRatingsTable reports. The brokerage currently has a “hold” rating on the health services provider’s stock. SunTrust Banks’ price target indicates a potential downside of 21.09% from the stock’s current price.
TDOC has been the topic of several other research reports. Wells Fargo & Co cut shares of Teladoc Health from an “overweight” rating to an “equal weight” rating and set a $105.00 price target on the stock. in a research report on Wednesday, February 12th. They noted that the move was a valuation call. JPMorgan Chase & Co. increased their price target on shares of Teladoc Health from $112.00 to $146.00 and gave the stock an “overweight” rating in a research report on Thursday, February 27th. Bank of America increased their price target on shares of Teladoc Health from $106.00 to $140.00 and gave the stock a “neutral” rating in a research report on Thursday, February 27th. Royal Bank of Canada increased their price target on shares of Teladoc Health from $140.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, March 6th. Finally, Jefferies Financial Group cut shares of Teladoc Health from a “buy” rating to a “hold” rating and set a $80.00 price target on the stock. in a research report on Friday, December 6th. Twelve research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $121.74.
Shares of TDOC traded up $7.42 during mid-day trading on Thursday, reaching $149.53. The stock had a trading volume of 3,443,980 shares, compared to its average volume of 4,757,314. The company has a debt-to-equity ratio of 0.43, a current ratio of 6.52 and a quick ratio of 6.52. Teladoc Health has a 52-week low of $48.57 and a 52-week high of $168.00. The business’s fifty day moving average is $124.32 and its 200 day moving average is $90.52. The firm has a market cap of $11.83 billion, a price-to-earnings ratio of -108.35 and a beta of 0.95.
In other news, insider Lewis Levy sold 2,025 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $84.00, for a total transaction of $170,100.00. Following the transaction, the insider now directly owns 5,655 shares in the company, valued at $475,020. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 3.95% of the stock is currently owned by company insiders.
Several institutional investors and hedge funds have recently made changes to their positions in the company. Total Clarity Wealth Management Inc. purchased a new position in Teladoc Health in the 4th quarter valued at $25,000. Tower Research Capital LLC TRC purchased a new stake in shares of Teladoc Health during the 4th quarter worth $28,000. Great Diamond Partners LLC purchased a new stake in shares of Teladoc Health during the 4th quarter worth $33,000. Citizens Financial Group Inc RI purchased a new stake in shares of Teladoc Health during the 4th quarter worth $34,000. Finally, Marshall Wace North America L.P. purchased a new stake in shares of Teladoc Health during the 1st quarter worth $35,000.
Teladoc Health Company Profile
Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
Featured Article: What are the economic characteristics of a bear market?
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.